A Pilot Study to Evaluate Renal Hemodynamics in Cirrhosis by Simultaneous Glomerular Filtration Rate, Renal Plasma Flow, Renal Resistive Indices and Biomarkers Measurements

Background: Renal hemodynamic measurements are complicated to perform in patients with cirrhosis, yet they provide the best measure of risk to predict hepatorenal syndrome (HRS). Currently, there are no established biomarkers of altered renal hemodynamics in cirrhosis validated by measured renal hemodynamics. Methods: In this pilot study, simultaneous measurements of glomerular filtration rate (GFR), renal plasma flow (RPF), renal resistive indices and biomarkers were performed to evaluate renal hemodynamic alterations in 10 patients with cirrhosis (3 patients without ascites, 5 with diuretic-sensitive and 2 diuretic-refractory ascites). Results: Patients with diuretic-refractory ascites had the lowest mean GFR (36.5 ml/min/1.73 m2) and RPF (133.6 ml/min/1.73 m2) when compared to those without ascites (GFR 82.9 ml/min/1.73 m2, RPF 229.9 ml/min/1.73 m2) and with diuretic-sensitive ascites (GFR 82.3 ml/min/1.73 m2, RPF 344.1 ml/min/1.73 m2). A higher mean filtration fraction (FF) (GFR/RPF 0.36) was noted among those without ascites compared to those with ascites. Higher FF in patients without ascites is most likely secondary to the vasoconstriction in the efferent glomerular arterioles (normal FF ∼0.20). In general, renal resistive indices were inversely related to FF. While patients with ascites had lower FF and higher right kidney main and arcuate artery resistive indices, those without ascites had higher FF and lower right kidney main and arcuate artery resistive indices. While cystatin C and β2-microglobulin performed better compared to Cr in estimating RPF, β-trace protein, β2-microglobulin, and SDMA, and (SDMA+ADMA) performed better in estimating right kidney arcuate artery resistive index. Conclusion: The results of this pilot study showed that identification of non-invasive biomarkers of reduced RPF and increased renal resistive indices can identify cirrhotics at risk for HRS at a stage more amenable to therapeutic intervention and reduce mortality from kidney failure in cirrhosis.

[1]  Constantine J Karvellas,et al.  Acute Kidney Injury in Cirrhosis. , 2015, Critical care clinics.

[2]  M. Perazella,et al.  Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury , 2014, Hepatology.

[3]  L. Magder,et al.  Performance of chronic kidney disease epidemiology collaboration creatinine‐cystatin C equation for estimating kidney function in cirrhosis , 2014, Hepatology.

[4]  G. Leoncini,et al.  Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient , 2013, Journal of hypertension.

[5]  M. Weir,et al.  Current Concepts in the Diagnosis and Classification of Renal Dysfunction in Cirrhosis , 2013, American Journal of Nephrology.

[6]  L. Beydon,et al.  Early detection of postoperative acute kidney injury by Doppler renal resistive index in cardiac surgery with cardiopulmonary bypass. , 2011, British journal of anaesthesia.

[7]  P. Ginès,et al.  Pharmacological management of hepatorenal syndrome: lessons from non-responders. , 2011, Journal of hepatology.

[8]  R. Bellomo,et al.  Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis , 2011, Gut.

[9]  E. Christensen,et al.  Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome , 2010, Hepatology.

[10]  E. Cholongitas,et al.  Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality , 2007, European journal of gastroenterology & hepatology.

[11]  G. Giebisch,et al.  GLOMERULAR FILTRATION AND RENAL BLOOD FLOW , 2009 .

[12]  Vicente Arroyo,et al.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.

[13]  Tom Greene,et al.  Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. , 2007, Clinical chemistry.

[14]  Vicente Arroyo,et al.  LIVER FAILURE AND LIVER DISEASE , 2005 .

[15]  M. Fisher,et al.  Nesiritide Does Not Improve Renal Function in Patients With Chronic Heart Failure and Worsening Serum Creatinine , 2004, Circulation.

[16]  D. Fish,et al.  Assessing renal function in cirrhotic patients: problems and pitfalls. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  M. Tublin,et al.  Correlation between renal vascular resistance, pulse pressure, and the resistive index in isolated perfused rabbit kidneys. , 1999, Radiology.

[18]  F. Salerno,et al.  Reduction of renal cortical blood flow assessed by doppler in cirrhotic patients with refractory ascites , 1998, Hepatology.

[19]  R. Frye,et al.  Simultaneous determination of p-aminohippuric acid, acetyl-p-aminohippuric acid and iothalamate in human plasma and urine by high-performance liquid chromatography. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[20]  G. Bartsch,et al.  Variability of Doppler parameters in the healthy kidney: an anatomic‐physiologic correlation. , 1995, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  M. Epstein,et al.  Hepatorenal syndrome: emerging perspectives. , 1997, Seminars in nephrology.

[22]  B. Befeler,et al.  Relationship of systemic and intrarenal hemodynamics in cirrhosis. , 1977, The Journal of laboratory and clinical medicine.

[23]  S. Sherlock,et al.  Renal and intrarenal blood-flow in cirrhosis of the liver. , 1971, Lancet.

[24]  T. Chalmers,et al.  Renal failure in the patient with cirrhosis. The role of active vasoconstriction. , 1970, The American journal of medicine.

[25]  E. P. Ralli,et al.  Renal function as a factor in fluid retention in patients with cirrhosis of the liver. , 1951, The Journal of clinical investigation.